Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Paola CoronaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-9182-478X
Stefania GessiDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Roberta IbbaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0003-3332-3845
Stefania MerighiDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0003-0839-6671
Prisco MirandolaDepartment of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy.
Gérard Aimè PinnaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
Manuela NigroDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Giulia PozziDepartment of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy.
Battistina AsproniDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-0988-1882
Alessia TravagliDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Sandra PirasDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
Antonio CartaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
Paola CariaDepartment of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.ORCID 0000-0003-3790-7688
Gabriele MurinedduDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-2791-9178
Funding
University of Sassari DM 737/2021 risorse 2022 - 2023, CUP J55F21004240001University of Sassari FAR2020CORONAPUniversity of Sassari FAR2020PINNAGA
6 · The paper itself
Abstract
A small library of 25 novel 1,3,4-oxadiazole-quinoxalines was synthesized and evaluated in vitro for its cytotoxic activity at 10 μM concentration against nine NCI-different cancer cell lines. Among tested compounds, derivatives
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity. · full record | OpenQuestion